Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [528] [529] [530] 531 [532] [533] [534] [535] Next Page Last Page Total 17946 items, Total 718 Page Goto
2A-3179611 |
(Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)Methyl)-2,4-diMethyl-1H-pyrrole-3-carboxaMide |
1186651-51-3 |
|
0% |
Inquiry |
2A-3179612 |
Sunitinib N-Oxide |
356068-99-0 |
|
0% |
Inquiry |
2A-3179613 |
Dabrafenib Desmethyl Impurity |
1195765-47-9 |
|
0% |
Inquiry |
2A-3179614 |
Dabrafenib Hydroxy |
1195767-77-1 |
|
0% |
Inquiry |
2A-3179615 |
Dabrafenib Carboxylic Acid |
1195873-54-1 |
|
0% |
Inquiry |
2A-3179616 |
α-Capecitabine |
2230479-30-6 |
|
0% |
Inquiry |
2A-3179617 |
Capecitabin iMpurity |
71609-08-0 |
|
0% |
Inquiry |
2A-3179618 |
Capecitabinealfa alfa impurity2 |
1810778-34-7 |
|
0% |
Inquiry |
2A-3179619 |
(3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(1,1-dioxidobenzo[d] isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl) hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
1807607-99-3 |
|
0% |
Inquiry |
2A-3179620 |
Lurasidon hydrochloride iMpurity |
1260138-03-1 |
|
0% |
Inquiry |
2A-3179621 |
Lurasidone Impurity |
1574569-32-6 |
|
0% |
Inquiry |
2A-3179622 |
(1S,4R)-3-((((1R,2R)-2-((4-(1-oxidobenzo[d]isothiazol-3-yl) piperazin-1-yl)methyl)cyclohexyl)methyl)carbamoyl)bicycle [2.2.1]heptane-2-carboxylic acid |
1644295-07-7 |
|
0% |
Inquiry |
2A-3179623 |
(3aR,4S,7R,7aS)-2-(((1S,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
1448443-35-3 |
|
0% |
Inquiry |
2A-3179624 |
(3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride |
139563-18-1 |
|
0% |
Inquiry |
2A-3179625 |
lurasidone-001-SS-Na |
136983-81-8 |
|
0% |
Inquiry |
2A-3179626 |
Lurasidone Impurity 17 |
1807983-67-0 |
|
0% |
Inquiry |
2A-3179627 |
Noreximide |
6319-06-8 |
|
0% |
Inquiry |
2A-3179628 |
UJXPPCDJYRWSLC-GIDHVPLMSA-N |
85026-47-7 |
|
0% |
Inquiry |
2A-3179629 |
PJARUKXCFRFPOP-JRTVQGFMSA-N |
1365987-23-0 |
|
0% |
Inquiry |
2A-3179630 |
((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7- methanoisoindol-2-yl)methyl)cyclohexyl)methyl 4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate |
1807983-62-5 |
|
0% |
Inquiry |
2A-3179631 |
((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) bis(4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate) |
1807983-61-4 |
|
0% |
Inquiry |
2A-3179632 |
IUCKBDGFLIFCCX-ZEQRLZLVSA-N |
1807983-63-6 |
|
0% |
Inquiry |
2A-3179633 |
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1) |
139563-24-9 |
|
0% |
Inquiry |
2A-3179634 |
R,R-endo-lurasidone HCl |
1318074-25-7 |
|
0% |
Inquiry |
2A-3179635 |
s,s-endo-lurasidone HCl |
1318074-27-9 |
|
0% |
Inquiry |
|
|
|
|